Sanai Health Industry Group
Market Cap
HK$276.1m
Last Updated
2021/04/11 10:17 UTC
Data Sources
Company Financials
Executive Summary
Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. More Details
Risk Analysis
Snowflake Analysis
Weak fundamentals or lack of information.
Share Price & News
How has Sanai Health Industry Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1889 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: Insufficient data to determine 1889's volatility change over the past year.
Market Performance
7 Day Return
0%
1889
0.8%
HK Pharmaceuticals
-1.1%
HK Market
1 Year Return
n/a
1889
21.2%
HK Pharmaceuticals
28.6%
HK Market
Return vs Industry: Insufficient data to determine how 1889 performed against the Hong Kong Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1889 performed against the Hong Kong Market.
Shareholder returns
| 1889 | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | 0.8% | -1.1% |
| 30 Day | 0% | 0.7% | -1.8% |
| 90 Day | 0% | 10.0% | 3.4% |
| 1 Year | n/a | 23.0%21.2% | 33.5%28.6% |
| 3 Year | -55.0%-55.0% | -14.3%-19.1% | 4.0%-6.9% |
| 5 Year | -72.7%-72.7% | 79.2%62.4% | 48.7%23.7% |
Long-Term Price Volatility Vs. Market
How volatile is Sanai Health Industry Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Sanai Health Industry Group undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Sanai Health Industry Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Sanai Health Industry Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
Future Growth
How is Sanai Health Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
18.2%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanai Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Sanai Health Industry Group performed over the past 5 years?
10.4%
Historical Pharmaceuticals & Biotech annual earnings growth
Earnings and Revenue History
Quality Earnings: 1889 has a high level of non-cash earnings.
Growing Profit Margin: Insufficient data to determine if 1889's profit margins have improved over the past year.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 1889's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 1889's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if 1889's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: 1889 has a negative Return on Equity (0%), as it is currently unprofitable.
Financial Health
How is Sanai Health Industry Group's financial position?
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if 1889's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if 1889's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate 1889's debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if 1889's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if 1889's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if 1889's interest payments on its debt are well covered by EBIT.
Balance Sheet
Dividend
What is Sanai Health Industry Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1889's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1889's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1889's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1889's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 1889 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1889's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.8yrs
Average board tenure
CEO
Sanai Health Industry Group has no CEO, or we have no data on them.
Board Members
Experienced Board: 1889's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Sanai Health Industry Group Company Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Sanai Health Industry Group Company Limited
- Ticker: 1889
- Exchange: SEHK
- Founded: 2006
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: HK$276.050m
- Shares outstanding: 3.07b
- Website: https://www.1889hk.com
Number of Employees
Location
- Sanai Health Industry Group Company Limited
- Nanyang Plaza
- 7th Floor
- Kwun Tong
- Kowloon
- Hong Kong
Listings
Biography
Sanai Health Industry Group Company Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People’s Republic of China. It operates through three s...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/11 10:17 |
| End of Day Share Price | 2021/04/09 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.